Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Accuray Incorporated - Common Stock (NQ:ARAY)

1.380 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,201
Open 1.380
Bid (Size) 1.400 (400)
Ask (Size) 1.420 (3,600)
Prev. Close 1.380
Today's Range 1.380 - 1.380
52wk Range 1.140 - 2.950
Shares Outstanding 95,751,773
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Accuray Q4 Revenue Hits $128 Million
Via The Motley Fool
Topics Economy World Trade
Accuray (ARAY) Q4 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings World Trade

Performance

YTD
-29.2%
-29.2%
1 Month
-19.3%
-19.3%
3 Month
+6.2%
+6.2%
6 Month
+6.2%
+6.2%
1 Year
-23.3%
-23.3%

More News

Read More
Accuray Inc (NASDAQ:ARAY) Reports Mixed Q4 2025 Earnings: Revenue Beat but EPS Miss Sparks 6% After-Hours Drop
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Earnings Scheduled For April 30, 2025
Via Benzinga
Insights Ahead: Accuray's Quarterly Earnings
Via Benzinga
Accuray Q2 Earnings Assessment
Via Benzinga
Earnings Scheduled For February 5, 2025
Via Benzinga
Earnings Scheduled For November 5, 2025
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Leo Cancer Care Unveils Revolutionary Upright Photon Therapy System: A Paradigm Shift in Cancer Treatment
Via MarketMinute
Topics Artificial Intelligence
Nanobiotix Stock Soars on Breakthrough Esophageal Cancer Data, Igniting Biotech Hopes
Via MarketMinute
A Glimpse of Accuray's Earnings Potential
Via Benzinga
Earnings Scheduled For August 13, 2025
Via Benzinga
Gapping stocks in Friday's session
Via Chartmill
Discover the top movers in Friday's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
ChatGPT Moment For Robotics Is Around The Corner Says Nvidia CEO
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Russell 2000 Set For Strongest Session In A Month As US Economy Defies Recession Fears: Small Cap Movers On Thursday
Via Benzinga
Topics ETFs Economy
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Lumentum Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Via Benzinga
ARAY Stock Earnings: Accuray Meets EPS, Beats Revenue for Q4 2024
Via InvestorPlace
3 Penny Stock Lotto Tickets With 100X Potential
Via InvestorPlace
3 Millionaire-Maker Penny Stocks Set to Surge by 1,000%: June Edition
Via InvestorPlace

Frequently Asked Questions

Is Accuray Incorporated - Common Stock publicly traded?
Yes, Accuray Incorporated - Common Stock is publicly traded.
What exchange does Accuray Incorporated - Common Stock trade on?
Accuray Incorporated - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Accuray Incorporated - Common Stock?
The ticker symbol for Accuray Incorporated - Common Stock is ARAY on the Nasdaq Stock Market
What is the current price of Accuray Incorporated - Common Stock?
The current price of Accuray Incorporated - Common Stock is 1.380
When was Accuray Incorporated - Common Stock last traded?
The last trade of Accuray Incorporated - Common Stock was at 11/04/25 04:00 PM ET
What is the market capitalization of Accuray Incorporated - Common Stock?
The market capitalization of Accuray Incorporated - Common Stock is 132.14M
How many shares of Accuray Incorporated - Common Stock are outstanding?
Accuray Incorporated - Common Stock has 132M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.